Global Organ Transplant Immunosuppressant Market 2017-2021

  • ID: 4328289
  • Report
  • Region: Global
  • 128 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Astellas Pharma
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Sanofi,AbbVie
  • MORE
About Organ Transplant Immunosuppressant

An organ transplantation is a surgical procedure that involves replacing diseased organs such as a heart, liver, kidney, or lung with healthy organs. The donor organ can come from a deceased donor (who has recently passed away) such as in heart transplants, or kidney, liver, and rarely lung transplants from living donors. As per the Centers for Disease Control and Prevention (CDC) report, the most commonly transplanted organs in the US are the kidney, liver, heart, lungs, pancreas, and intestine. On any given day, there are about 75,000 people on active waiting list for organ transplantation. However, the organ donors are very few, leading to the high unmet need for organ availability. There are only 8,000 deceased organ donors annually, with each providing on average 3.5 organs. Living donors provide on average only around 6,000 organs per year.

The analysts forecast the global organ transplant immunosuppressant market to grow at a CAGR of 3.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global organ transplant immunosuppressant market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Organ Transplant Immunosuppressant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Novartis,
  • Astellas Pharma,
  • Pfizer,
  • Sanofi,
Other prominent vendors
  • AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
Market drivers
  • Increased incidence of organ failure
  • For a full, detailed list, view the full report
Market challenges
  • Insufficient organ supply
  • For a full, detailed list, view the full report
Market trends
  • Growing trend of medical tourism
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Astellas Pharma
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Sanofi,AbbVie
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Introduction to organ transplantation
  • What is an organ transplantation?
  • How common is organ transplantation?
  • Increasing trend of organ transplantation
  • Need for immunosuppression during organ transplant
  • What is an immunosuppressant?
  • Role of an immunosuppressant during organ transplant
PART 06: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 07: Key clinical trials

PART 08: Market segmentation by drug class
  • Selective inhibitor of cytokine production and function
  • Immunosuppressive antimetabolites
  • Immunosuppressive antibodies
  • Immunosuppressive adrenocorticosteroids
PART 09: Market segmentation by therapeutic application
  • Kidney transplantation
  • Liver transplantation
  • Heart transplantation
  • Lung transplantation
  • Pancreas transplantation
  • Other transplantation
PART 10: Geographical segmentation
  • Organ transplant immunosuppressant market in Americas
  • Organ transplant immunosuppressant market in EMEA
  • Organ transplant immunosuppressant market in APAC
PART 11: Decision framework

PART 12: Drivers and challenges
  • Market drivers
  • Market challenges
PART 13: Market trends
  • Growing trend of medical tourism
  • New government initiatives on transplant research programs
  • Growing focus toward the use of biologics
PART 14: Vendor landscape
  • Competitive scenario
PART 15: Key vendor analysis
  • Astellas Pharma
  • Novartis
  • Pfizer
  • Sanofi
  • Other prominent vendors
PART 16: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Market share of global organ transplant immunosuppressant market in the global immunology market 2016
Exhibit 02: Factors driving the global organ transplant immunosuppressant market 2016
Exhibit 03: Types of immunosuppressant
Exhibit 04: Prevalence rate of kidney and liver diseases in US adults over 18 years of age 2015
Exhibit 05: Increasing trend of transplantation in US 2003-2015
Exhibit 06: Kidney and liver transplant market scenario: Deceased donors versus living donors 2014
Exhibit 07: Global organ transplant immunosuppressant market 2016-2021 ($ millions)
Exhibit 08: Opportunity analysis in global organ transplant immunosuppressant market
Exhibit 09: Five forces analysis
Exhibit 10: Pipeline landscape based on mechanism of action (MoA)
Exhibit 11: Key clinical trials
Exhibit 12: Key clinical studies
Exhibit 13: Clinical studies for kidney transplant
Exhibit 14: Segmentation of global organ transplant immunosuppressant market by drug class 2016
Exhibit 15: Global organ transplant immunosuppressant market share by drug class 2016
Exhibit 16: Examples of selective inhibitors of cytokine production and function
Exhibit 17: Global organ transplant immunosuppressive selective inhibitor of cytokine production and function market 2016-2021 ($ millions)
Exhibit 18: Examples of immunosuppressive antimetabolites
Exhibit 19: Global organ transplant immunosuppressive antimetabolites market 2016-2021 ($ millions)
Exhibit 20: Examples of immunosuppressive antibodies
Exhibit 21: Global organ transplant immunosuppressive antibodies market revenue 2016-2021 ($ millions)
Exhibit 22: Examples of immunosuppressive adrenocorticosteroids
Exhibit 23: Global organ transplant immunosuppressive adrenocorticosteroids market revenue 2016-2021 ($ millions)
Exhibit 24: Segmentation of global organ transplant immunosuppressant market by therapeutic application 2016
Exhibit 25: Segmentation of global organ transplant immunosuppressant market by geography 2016 and 2021
Exhibit 26: Global organ transplant immunosuppressant market revenue by geography 2016-2021 ($ millions)
Exhibit 27: Global organ transplant immunosuppressant market share by geography 2016 (%)
Exhibit 28: Market scenario in Americas
Exhibit 29: Organ transplant immunosuppressant market in Americas 2016-2021 ($ millions)
Exhibit 30: Market scenario in EMEA
Exhibit 31: Organ transplant immunosuppressant market in EMEA 20016-2021 ($ millions)
Exhibit 32: Market scenario in APAC
Exhibit 33: Organ transplant immunosuppressant market in APAC 2016-2021 ($ millions)
Exhibit 34: Types of transplant rejection
Exhibit 35: Classification of some of the marketed immunosuppressive drugs based on their MoA
Exhibit 36: Organ transplantation scenario in US 2003-2015
Exhibit 37: Donation trend over the years: 2000-2010
Exhibit 38: Legal and ethical issues in some countries
Exhibit 39: Contribution by governments and its market impact
Exhibit 40: Competitive structure analysis of global organ transplant immunosuppressant market 20161
Exhibit 41: Astellas Pharma: Key highlights
Exhibit 42: Astellas Pharma: Strength assessment
Exhibit 43: Astellas Pharma: Strategy assessment
Exhibit 44: Astellas Pharma: Opportunity assessment
Exhibit 45: Novartis: Key highlights
Exhibit 46: Novartis: Strength assessment
Exhibit 47: Novartis: Strategy assessment
Exhibit 48: Novartis: Opportunity assessment
Exhibit 49: Pfizer: Key highlights
Exhibit 50: Pfizer: Strength assessment
Exhibit 51: Pfizer: Strategy assessment
Exhibit 52: Pfizer: Opportunity assessment
Exhibit 53: Sanofi: Key highlights
Exhibit 54: Sanofi: Strength assessment
Exhibit 55: Sanofi: Strategy assessment
Exhibit 56: Sanofi: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Astellas Pharma
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Novartis
  • Pfizer
  • Sanofi,AbbVie
  • MORE
New Report Released: - Global Organ Transplant Immunosuppressant Market 2017-2021

The author of the report recognizes the following companies as the key players in the global organ transplant immunosuppressant market: Novartis, Astellas Pharma, Pfizer, and Sanofi,

Other Prominent Vendors in the market are: AbbVie, Bristol-Myers Squibb, and F. Hoffmann-La Roche.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is growing trend of medical tourism. Medical tourism is the act of traveling abroad to receive medical, dental, and cosmetic care. Medical tourism for getting an organ transplant is also called as transplant tourism, and the significantly lower cost for availing the best practice care is generally the primary motivation. In addition, the insufficient organ supply is another reason for the emergence of medical/transplant tourism. However, to bridge the gap between demand and supply, the introduction of the artificial organ has served the purpose. However, the high cost associated with artificial organ transplant, especially in the US has further compelled the individuals to visit the less developed countries to get an organ transplant at competitive prices.”

According to the report, one of the major drivers for this market is increased incidence of organ failure. Globally, there is a high demand for tissues and organs such as bone marrow, heart, liver, kidney, and lungs. The increased alcohol consumption, unhealthy lifestyles and food habits, and drug intake are the leading causes of organ failure. In addition, the rise in aging population results in increased demand for organs for transplantation.

Further, the report states that one of the major factors hindering the growth of this market is Insufficient organ supply. The global organ transplant immunosuppressant market is witnessing a high demand for donor organ due to increasing incidences of organ failure. Despite advances in the medicine and technology, and increased awareness of organ donation and transplantation, the increasing gap between supply and demand continues to pose a major challenge for the market growth.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Novartis
  • Astellas Pharma
  • Pfizer
  • Sanofi,AbbVie
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll